Isophane Protamine Recombinant Human Insulin(Jilin Huisheng Biological Pharmaceutical Co., Ltd.)

1. Using Novolin@N as a positive control, a randomized controlled clinical trial was conducted to verify the effectiveness of protamine recombinant human insulin injection produced by Jilin Huisheng Biopharmaceutical Co., Ltd. as an insulin starting treatment for patients with type 2 diabetes who are poorly controlled by oral hypoglycemic drugs. 2. The safety of protamine recombinant human insulin injection was verified through laboratory tests, clinical symptoms, signs, adverse events/serious adverse events, etc.